Imoxiterol

This classification denotes a beta-adrenergic agonist, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier UR4924C6G2. European Medicines Agency schedules Imoxiterol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08157MIG. Imoxiterol generally arises in the molecular formula C20H25N3O3. The term IMOXITEROL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 39, no. 5, 1985, list 25.) IMOXITEROL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule Imoxiterol under HS 29339990 and SITC 51577. As of Q4 2014, IMOXITEROL remains the US FDA Preferred Term for this commodity. Imoxiterol bears US NLM identifiers UMLS ID C2827197 and NCI Concept Code C83794. SMILES: CC(CCN1CNC2C1CCCC2)NCC(C3CCC(C(C3)OC)O)O.